176 related articles for article (PubMed ID: 23564621)
1. Comparison of direct-measured and derived short form six dimensions (SF-6D) health preference values among chronic hepatitis B patients.
Wong CK; Lam ET; Lam CL
Qual Life Res; 2013 Dec; 22(10):2973-81. PubMed ID: 23564621
[TBL] [Abstract][Full Text] [Related]
2. Health-related quality of life of Southern Chinese with chronic hepatitis B infection.
Lam ET; Lam CL; Lai CL; Yuen MF; Fong DY; So TM
Health Qual Life Outcomes; 2009 Jun; 7():52. PubMed ID: 19500349
[TBL] [Abstract][Full Text] [Related]
3. SF-6D population norms for the Hong Kong Chinese general population.
Wong CKH; Mulhern B; Cheng GHL; Lam CLK
Qual Life Res; 2018 Sep; 27(9):2349-2359. PubMed ID: 29797176
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the preference-based EQ-5D-5L and SF-6D in patients with end-stage renal disease (ESRD).
Yang F; Lau T; Lee E; Vathsala A; Chia KS; Luo N
Eur J Health Econ; 2015 Dec; 16(9):1019-26. PubMed ID: 25519850
[TBL] [Abstract][Full Text] [Related]
5. Preference-based SF-6D scores derived from the SF-36 and SF-12 have different discriminative power in a population health survey.
Luo N; Wang P; Fu AZ; Johnson JA; Coons SJ
Med Care; 2012 Jul; 50(7):627-32. PubMed ID: 22456112
[TBL] [Abstract][Full Text] [Related]
6. Predicting the short form-6D preference-based index using the eight mean short form-36 health dimension scores: estimating preference-based health-related utilities when patient level data are not available.
Ara R; Brazier J
Value Health; 2009; 12(2):346-53. PubMed ID: 18647248
[TBL] [Abstract][Full Text] [Related]
7. Validation and comparison of EuroQol and short form 6D in chronic prostatitis patients.
Zhao FL; Yue M; Yang H; Wang T; Wu JH; Li SC
Value Health; 2010 Aug; 13(5):649-56. PubMed ID: 20412540
[TBL] [Abstract][Full Text] [Related]
8. A comparison of utility measurement using EQ-5D and SF-6D preference-based generic instruments in patients with rheumatoid arthritis.
Salaffi F; Carotti M; Ciapetti A; Gasparini S; Grassi W
Clin Exp Rheumatol; 2011; 29(4):661-71. PubMed ID: 21813061
[TBL] [Abstract][Full Text] [Related]
9. A preference-based measure of health: the VR-6D derived from the veterans RAND 12-Item Health Survey.
Selim AJ; Rogers W; Qian SX; Brazier J; Kazis LE
Qual Life Res; 2011 Oct; 20(8):1337-47. PubMed ID: 21336657
[TBL] [Abstract][Full Text] [Related]
10. A Comparison of UK and Brazilian SF-6D Preference Weights When Applied to a Brazilian Urban Population.
Ferraz MB; Nardi EP; Campolina AG
Value Health Reg Issues; 2019 Dec; 20():21-27. PubMed ID: 30634088
[TBL] [Abstract][Full Text] [Related]
11. A head-to-head comparison of EQ-5D-5 L and SF-6D in Chinese patients with low back pain.
Ye Z; Sun L; Wang Q
Health Qual Life Outcomes; 2019 Apr; 17(1):57. PubMed ID: 30971265
[TBL] [Abstract][Full Text] [Related]
12. Chilean population norms derived from the health-related quality of Life SF-6D.
Garcia-Gordillo MA; Collado-Mateo D; Olivares PR; Adsuar JC
Eur J Health Econ; 2018 Jun; 19(5):675-686. PubMed ID: 28631248
[TBL] [Abstract][Full Text] [Related]
13. Predicting preference-based SF-6D index scores from the SF-8 health survey.
Wang P; Fu AZ; Wee HL; Lee J; Tai ES; Thumboo J; Luo N
Qual Life Res; 2013 Sep; 22(7):1675-83. PubMed ID: 23054496
[TBL] [Abstract][Full Text] [Related]
14. Quality of life in cochlear implantees: comparing utility values obtained through the Medical Outcome Study Short-Form Survey-6D and the Health Utility Index Mark 3.
Arnoldner C; Lin VY; Bresler R; Kaider A; Kuthubutheen J; Shipp D; Chen JM
Laryngoscope; 2014 Nov; 124(11):2586-90. PubMed ID: 24536018
[TBL] [Abstract][Full Text] [Related]
15. Comparison of EQ-5D and SF-6D utilities in Pompe disease.
Kanters TA; Redekop WK; Kruijshaar ME; van der Ploeg AT; Rutten-van Mölken MP; Hakkaart L
Qual Life Res; 2015 Apr; 24(4):837-44. PubMed ID: 25342117
[TBL] [Abstract][Full Text] [Related]
16. Impact of chronic liver disease and cirrhosis on health utilities using SF-6D and the health utility index.
Dan AA; Kallman JB; Srivastava R; Younoszai Z; Kim A; Younossi ZM
Liver Transpl; 2008 Mar; 14(3):321-6. PubMed ID: 18306356
[TBL] [Abstract][Full Text] [Related]
17. Comparing the Health Utilities Index Mark 3 (HUI3) with the Short Form-36 preference-based SF-6D in chronic kidney disease.
Davison SN; Jhangri GS; Feeny DH
Value Health; 2009; 12(2):340-5. PubMed ID: 18657096
[TBL] [Abstract][Full Text] [Related]
18. Interchangeability of the EQ-5D and the SF-6D, and comparison of their psychometric properties in a spinal postoperative Spanish population.
Selva-Sevilla C; Ferrara P; Gerónimo-Pardo M
Eur J Health Econ; 2020 Jun; 21(4):649-662. PubMed ID: 32065301
[TBL] [Abstract][Full Text] [Related]
19. The development of a model for translation of the Neck Disability Index to utility scores for cost-utility analysis in cervical disorders.
Richardson SS; Berven S
Spine J; 2012 Jan; 12(1):55-62. PubMed ID: 22209244
[TBL] [Abstract][Full Text] [Related]
20. Baseline comparison of three health utility measures and the feeling thermometer among participants in the Action to Control Cardiovascular Risk in Diabetes trial.
Raisch DW; Feeney P; Goff DC; Narayan KM; O'Connor PJ; Zhang P; Hire DG; Sullivan MD
Cardiovasc Diabetol; 2012 Jul; 11():35. PubMed ID: 22515638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
